2021
DOI: 10.1016/j.jddst.2021.102756
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and evaluation of gemcitabin and cisplatin-entrapped Folate-PEGylated liposomes as targeting co-drug delivery system in cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…PEGylation of nanoparticles can not only facilitate the passive targeting of cancer cells but also increase their hydrophilicity, avoid the immune system response, and increase the circulation time of nano-complex in body serum. [21,22,23] Moreover, in active tumor targeting, conjugating folic acid and anti-FR antibodies with nanocarriers can considerably raise the internalization efficiency of nanocarriers by cancer cells via folate receptor-mediated endocytosis. [24,25] In this strategy, the cellular uptake of nanocarriers can increase by ten-fold compared with non-targeted drug delivery systems and administration of pure chemotherapeutics.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…PEGylation of nanoparticles can not only facilitate the passive targeting of cancer cells but also increase their hydrophilicity, avoid the immune system response, and increase the circulation time of nano-complex in body serum. [21,22,23] Moreover, in active tumor targeting, conjugating folic acid and anti-FR antibodies with nanocarriers can considerably raise the internalization efficiency of nanocarriers by cancer cells via folate receptor-mediated endocytosis. [24,25] In this strategy, the cellular uptake of nanocarriers can increase by ten-fold compared with non-targeted drug delivery systems and administration of pure chemotherapeutics.…”
Section: Introductionmentioning
confidence: 99%
“…The particle size, shape, and surface chemistry of nanoparticles can affect the efficiency of the enhanced permeability and retention (EPR) effect due to the enhanced passive drug targeting. PEGylation of nanoparticles can not only facilitate the passive targeting of cancer cells but also increase their hydrophilicity, avoid the immune system response, and increase the circulation time of nano‐complex in body serum [21,22,23] . Moreover, in active tumor targeting, conjugating folic acid and anti‐FR antibodies with nanocarriers can considerably raise the internalization efficiency of nanocarriers by cancer cells via folate receptor‐mediated endocytosis [24,25] .…”
Section: Introductionmentioning
confidence: 99%